Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion type Assertion NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_head.
- NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_provenance.
- NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion evidence source_evidence_literature NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_provenance.
- NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion SIO_000772 16507781 NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_provenance.
- NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion wasDerivedFrom gad-20150221 NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_provenance.
- NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_assertion wasGeneratedBy ECO_0000203 NP99227.RAjlYpIdmVOYpWMFj8u9VLgwTY4malt_K9xwu0SrvGhxE130_provenance.